Genetic Predisposition Clinical Trial
Official title:
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain significance (VUS). The name of the intervention used in this research study is: Nest portal (electronic platform for patients and clinicians)
The goal of the electronic platform Nest is to help patients understand and manage genetic test results and recommended care and to help clinicians with access to results and recommendations, facilitating orders, and documentation. The portal has two parts, one for participants and one for clinicians. For the first phase of the study, participants will give their feedback on the Nest portal's content and processes that will guide refinement of the portal. The Pilot phase will test the feasibility and acceptability of the intervention. The research study procedures include a baseline survey, using the portal after receiving a brief orientation from the study team, a follow-up survey, and then a 30-minute interview. Participants will be in this research study for up to 2 hours. It is expected that about 40 people will take part in this research study. The electronic platform is being developed by Nest Genomics. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04746794 -
Early Detection of GEnetic Risk (EDGE)
|
N/A | |
| Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
| Recruiting |
NCT04970056 -
Pancreatic Cancer Early Detection Consortium
|
||
| Terminated |
NCT04119596 -
Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease
|
||
| Recruiting |
NCT04141462 -
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
|
N/A | |
| Completed |
NCT02826330 -
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
|
||
| Recruiting |
NCT05929976 -
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
|
||
| Not yet recruiting |
NCT04620278 -
Genetic Investigation of Cancer Predisposition
|
||
| Active, not recruiting |
NCT02373709 -
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
|
||
| Not yet recruiting |
NCT06089421 -
Genetic Information Assistant in Telegenetics
|
N/A | |
| Completed |
NCT05975489 -
Genetics in the Effect of Caffeine on Fat Oxidation
|
N/A | |
| Completed |
NCT03954652 -
Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"
|
N/A | |
| Completed |
NCT04113239 -
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
|
||
| Enrolling by invitation |
NCT04373525 -
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
|
||
| Completed |
NCT03362099 -
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
|
Phase 4 | |
| Recruiting |
NCT05857670 -
Psyco Quality of Life and Procreation BRCA1/2
|
||
| Active, not recruiting |
NCT04774445 -
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
|
N/A | |
| Not yet recruiting |
NCT06377033 -
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
|
N/A | |
| Active, not recruiting |
NCT04920513 -
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
|
||
| Active, not recruiting |
NCT04781205 -
Genome Driven Primary Care Clinics - an RCT
|
N/A |